HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides

Journal of Immunology

Volumn 169, Issue 9, 2002, Pages 5052-5060

  Muntasell, Aura ^a   Carrascal, Montserrat ^a   Serradell, Laurence ^a   Van Veelen, Peter ^a   Verreck, Frank ^a   Koning, Frits ^a   Raposo, Graça ^a   Abián, Joaquín ^a   Jaraquemada, Dolores ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DR ANTIGEN; HLA DR4 ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CELL LYSATE; ELECTRON MICROSCOPY; ENDOCYTOSIS; EPITHELIUM CELL; FLOW CYTOMETRY; HLA SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INTERNALIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUROSECRETORY CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT;

EID: 0036838610     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.9.5052     Document Type: Article

References (66)

1. Roche, P. A., M. S. Marks. and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class Il glycoproteins and the invariant chain. Nature 354:392.
2. Warmerdam, P. A., E. O. Long, and P. A. Roche. 1996. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments J. Cell Biol. 133:281.
3. Maric, M. A., M. D. Taylor, and J. S. Blum. 1994. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA 91:2171.
4. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
5. Kropshofer, H., G. J. Hammerling, and A. B. Vogt. 1997. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 18:77.
6. Alfonso, C., M. Liljedahl, O. Winqvist, C. D. Surh. P. A. Peterson, W. P. Fung-Leung, and L. Karlsson. 1999. The role of H2-O and HLA-DO in major histocompatibility complex class U-restricted antigen processing and presentation. Immunol. Rev. 172:255.
7. Peters, P. J., G. Raposo, J. J. Neefjes, V. Oorschot, R. L. Leijendekker, H. J. Geuze. and H. L. Ploegh. 1995. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J. Exp. Med. 182:325.
8. Kleijmeer, M. J., G. Raposo, and H. J. Geuze. 1996. Characterization of MHC class II compartments by immunoelectron microscopy. Methods 10:191.
9. Pond, L., and C. Watts. 1997. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. J. Immunol. 159:543.
10. Bottazzo, G. F., R. Pujol-Borrell, T. Hanafusa, and M. Feldmann 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115.
11. Bottazzo, G. F., M. Londei, E. Bosi, R. Mirakian, A. Belfiore, P. G. De Berardinis, I. Todd, R. Pujol-Borrell, and M. Feldmann. 1986. Inappropriate HLA class II expression on epithelial cells: New insight in the pathogenesis of distinctive autoimmunity. Ann. Ital. Med. Int. 1:20.
12. Feldmann, M., M. Londei, and G. Essery. 1986. Autoimmune disease: synergy of HLA class Il overexpression and abrogation of self tolerance. Pathol. Biol. 34:779.
13. Feldmann, M., M. Londei, M. Kissonerghis, G. Portillo, Z. Leech, A. Ziegler, and B. Grubeck-Loebenstein. 1988. Regulation of HLA class II expression and the pathogenesis of autoimmunity. Concepts Immunopathol. 5:44.
14. + T lymphocytes. J. Immunol. 160:661.
15. Huang, A. Y., A. T. Bruce, D. M. Pardoll, and H. I. Levitsky. 1996. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4:349.
16. Weetman, A. P. 1994. The potential immunological role of the thyroid cell in autoimmune thyroid disease. Thyroid 4:493.
17. Markmann, J., D. Lo, A. Naji, R. D. Palmiter, R. L. Brinster, and E. Heber-Katz. 1988. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 336:476.
18. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
19. Marrack, P., L. Ignatowicz, J. W. Kappler, J. Boymel, and J. H. Freed. 1993. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 178:2173.
20. Londei, M., G. F. Bottazzo, and M. Feldmann. 1985. Human T-cell clones from autoimmune thyroid glands: Specific recognition of autologous thyroid cells. Science 228:85.
21. Weetman, A. P., D. J. Volkman, K. D. Burman, J. B. Margolick, P. Petrick. B. D. Weintraub, and A. S. Fauci. 1986. The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. Clin. Immunol. Immunopathol. 39:139.
22. Dayan, C. M., M. Londei, A. E. Corcoran, B. Grubeck-Loebenstein, R. F. James, B. Rapoport, and M. Feldmann. 1991. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl. Acad. Sci. USA 88:7415.
23. Quaratino, S., M. Feldmann, C. M. Dayan, O. Acuto, and M. Londei. 1996. Human self-reactive T cell clones expressing identical T cell receptor β chains differ in their ability to recognize a cryptic self-epitope. J. Exp. Med. 183:349.
24. Bach, J. F., S. Koutouzov, and P. M. van Endert. 1998. Are there unique autoantigens triggering autoimmune diseases? Immunol. Rev. 164:139.
25. Gazdar, A. F., W. L. Chick, H. K. Oie, H. L. Sims, D. L. King, G. C. Weir. and V. Lauris. 1980. Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc. Natl. Acad. Sci. USA 77:3519.
26. Serradell, L., A. Muntasell, M. Catalfamo, M. Marti, M. Costa, C. de Preval, and D. Jaraquemada. 1999. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells. Tissue Antigens 53:447.
27. Roep, B. O., S. D. Arden, R. R. de Vries, and J. C. Hutton. 1990. T-cell clones from a type-I diabetes patient respond to insulin secretory granule proteins. Nature 345:632.
28. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: First listing. Immunogenetics 41:178.
29. Catalfamo, M., L. Serradell, C. Roura-Mir, E. Kolkowski, M. Sospedra, M. Vives-Pi, F. Vargas-Nieto, R. Pujol-Borrell, and D. Jaraquemada. 1999. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. Int. Immunol. 11:269.
30. Rammensee, H. G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7:85.
31. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1994. Pool sequencing of natural HLA-DR. DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics 39:230.
32. Lampson, L. A., and R. Levy. 1980. Two populations of la-like molecules on a human B cell line. J. Immunol. 125:293.
33. Morton, P. A., M. L. Zacheis, K. S. Giacoletto, J. A. Manning, and B. D. Schwartz. 1995. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154:137.
34. Sanderson, F., M. J. Kleijmeer, A. Kelly, D. Verwoerd, A. Tulp, J. J. Neefjes, H. J. Geuze, and J. Trowsdale. 1994. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566.
35. Quaranta, V., O. Majdic, G. Stingl, K. Liszka, H. Honigsmann, and W. Knapp. 1984. A human la cytoplasmic determinant located on multiple forms of invariant chain (γ, γ2, γ3). J. Immunol. 132:1900.
36. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1:595.
37. Raposo, G., M. J. Kleijmeer, G. Posthuma, J. W. Slot, and H. J. Geuze. 1997. Immunogold labeling of ultrathin cryosections: Application in immunology. In Handbook of Experimental Immunology, 5th Ed. I. Blackwell Science, ed. Elsevier, Cambridge, p. 1.
38. Slot, J. W., H. J. Geuze, and A. J. Weerkamp. 1988. Localization of macromolecular components by application of the immunogold technique on cryosected bacteria. Methods Microbiol. 21:211.
39. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
40. O'Sullivan, D., T. Arrhenius, J. Sidney, M. F. Del Guercio, M. Albertson, M. Wall, C. Oseroff, S. Southwood, S. M. Colon, F. C. Gaeta. et al. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles: Identification of common structural motifs. J. Immunol. 147:2663.
41. Hill, C. M., J. D. Hayball, A. A. Allison, and J. B. Rothbard. 1991. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J. Immunol. 147:189.
42. Kleijmeer, M. J., S. Morkowski, J. M. Griffith, A. Y. Rudensky, and H. J. Geuze. 1997. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139:639.
43. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197.
44. Hammer, J., E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353.
45. Hill, C. M., A. Liu, K. W. Marshall, J. Mayer, B. Jorgensen, B. Yuan, R. M. Cubbon, E. A. Nichols, L. S. Wicker, and J. B. Rothbard. 1994. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152:2890.
46. Pujol-Borrell R., I. Todd, M. Londei, A. Foulis, M. Feldmann, and G. F. Bottazzo. 1986. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic β cells in type I diabetes. Mol. Biol. Med. 3:159.
47. Hanafusa, T., R. Pujol-Borrell, L. Chiovato, R. C. Russell, D. Doniach, and G. F. Bottazzo. 1983. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity. Lancet 2:1111.
48. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M. T. Femandez-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Marti, D. Jaraquemada. et al. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus: Changes in HLA. adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J. Immunol. 153:1360.
49. Londei, M., J. R. Lamb, G. F. Bottazzo, and M. Feldmann. 1984. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639.
50. Lombardi. G., K. Arnold, J. Uren, F. Marelli-Berg, R. Hargreaves, N. Imami, A. Weetman, and R. Lechler. 1997. Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur. J. Immunol. 27:62.
51. Friede, T., V. Gnau, G. Jung, W. Keilholz, S. Stevanovic, and H. G. Rammensee. 1996. Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochim. Biophys. Acta 1316:85.
52. Rudensky, A., P. Preston-Hurlburt, S. C. Hong, A. Barlow, and C. A. Janeway. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
53. Karlsson, L., C. D. Surh, J. Sprent, and P. A. Peterson. 1991. A novel class Il MHC molecule with unusual tissue distribution. Nature 351:485.
54. Kropshofer, H., A. B. Vogt, C. Thery, E. A. Armandola, B. C. Li, G. Moldenhauer, S. Amigorena, and G. J. Hammerling. 1998. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class Il molecules. EMBO J. 17:2971.
55. Kropshofer, H., G. J. Hammerling, and A. B. Vogt. 1999. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172:267.
56. Van Lith, M., M. van Ham, A. Griekspoor, E. Tjin, D. Verwoerd, J. Calafat, H. Janssen, E. Reits, L. Pastoors, and J. Neefjes. 2001. Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 167:884.
57. Dongre, A. R., S. Kovats, P. deRoos, A. L. McCormack, T. Nakagawa, V. Paharkova-Vatchkova, J. Eng, H. Caldwell, J. R. Yates 3rd. and A. Y. Rudensky. 2001. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31:1485.
58. Lich, J. D., J. F. Elliott, and J. S. Blum. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J. Exp. Med. 191:1513.
59. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13.
60. Gromme, M., F. G. Uytdehaag, H. Janssen, J. Calafat, R. S. van Binnendijk, M. J. Kenter, A. Tulp, D. Verwoerd, and J. Neefjes. 1999. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. USA 96:10326.
61. Pierre, P., and I. Mellman. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93:1135.
62. Pathak, S. S., J. D. Lich, and J. S. Blum. 2001. Cutting edge: editing of recycling class ii:peptide complexes by HLA-DM. J. Immunol. 167:632.
63. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375:603.
64. Pinet, V. M., and E. O. Long. 1998. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur. J. Immunol. 28:799.
65. Kropshofer, H., S. Spindeldreher, T. A. Rohn, N. Platania, C. Grygar, N. Daniel, A. Wolpl, H. Langen, V. Horejsi, and A. B. Vogt. 2002. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3:61.
66. Castano, L., E. Russo, L. Zhou, M. A. Lipes, and G. S. Eisenbarth. 1991. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J. Clin. Endocrinol. Metab. 73:1197.